TabsDetailsBasic DetailsDate Posted: Monday, July 17, 2017Status: CompleteMedical Product: Actemra, tocilizumabHealth Outcome(s): juvenile rheumatoid arthritisrheumatoid arthritisDescription: This report contains estimates of tocilizumab use that occurred during a pregnancy resulting in a liveborn delivery, or within 90 days prior to the estimated start of pregnancy. This query request was distributed to 16 Data Partners on February 9, 2017, and requested data that spanned from the time period of January 1, 2010 to Septemeber 30, 2015. Read More Deliverables (1)Sentinel Modular Program Report: Actemra (Tocilizumab) Use Among Pregnant WomenAdditional InformationAdditional DetailsFDA Center: CDERTime Period: 2010 - 2015Study Type: Modular ProgramAssessment Type: Exploratory AnalysesPopulation / Cohort: All females 15 to 54 years of age with a live birth between January 2010 - December 2015
